Trial intelligence / Profile preview

Insulin detemir vs NPH insulin on energy balance in type 2 diabetes

2007-003085-17Phase 4Completed

Sponsor
University of Surrey
Start
Nov 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of insulin detemir in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of Surrey. Primary endpoint: Energy expenditure after treatment. Started Nov 2007; status: completed.

02

Drugs

insulin detemir
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2007-003085-17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003085-17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call